These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 1653630

  • 41. Reduction of drug accumulation and DNA topoisomerase II activity in acquired teniposide-resistant human cancer KB cell lines.
    Matsuo K, Kohno K, Takano H, Sato S, Kiue A, Kuwano M.
    Cancer Res; 1990 Sep 15; 50(18):5819-24. PubMed ID: 2168282
    [Abstract] [Full Text] [Related]

  • 42. Subcellular distribution of the alpha and beta topoisomerase II-DNA complexes stabilized by VM-26.
    Danks MK, Qiu J, Catapano CV, Schmidt CA, Beck WT, Fernandes DJ.
    Biochem Pharmacol; 1994 Nov 01; 48(9):1785-95. PubMed ID: 7980648
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. DNA topoisomerase II isozymes involved in anticancer drug action and resistance.
    Fernandes DJ, Qiu J, Catapano CV.
    Adv Enzyme Regul; 1995 Nov 01; 35():265-81. PubMed ID: 7572348
    [Abstract] [Full Text] [Related]

  • 45. Unknotting the complexities of multidrug resistance: the involvement of DNA topoisomerases in drug action and resistance.
    Beck WT.
    J Natl Cancer Inst; 1989 Nov 15; 81(22):1683-5. PubMed ID: 2553990
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I.
    Andoh T, Ishii K, Suzuki Y, Ikegami Y, Kusunoki Y, Takemoto Y, Okada K.
    Proc Natl Acad Sci U S A; 1987 Aug 15; 84(16):5565-9. PubMed ID: 3039492
    [Abstract] [Full Text] [Related]

  • 52. [A DNA topoisomerase from trypanosomes able to catenate, decatenate and unknot DNA without ATP].
    Douc-Rasy S, Riou JF, Kayser A, Riou G.
    C R Acad Sci III; 1986 Aug 15; 302(8):283-6. PubMed ID: 3011222
    [Abstract] [Full Text] [Related]

  • 53. Iridoids as DNA topoisomerase I poisons.
    Gálvez M, Martín-Cordero C, Ayuso MJ.
    J Enzyme Inhib Med Chem; 2005 Aug 15; 20(4):389-92. PubMed ID: 16206835
    [Abstract] [Full Text] [Related]

  • 54. DNA-unwinding test using eukaryotic DNA topoisomerase I.
    Shen LL.
    Methods Mol Biol; 2001 Aug 15; 95():149-60. PubMed ID: 11089228
    [No Abstract] [Full Text] [Related]

  • 55. Reduced DNA topoisomerase II activity in ataxia-telangiectasia cells.
    Singh SP, Mohamed R, Salmond C, Lavin MF.
    Nucleic Acids Res; 1988 May 11; 16(9):3919-29. PubMed ID: 2836804
    [Abstract] [Full Text] [Related]

  • 56. Differences between normal and ras-transformed NIH-3T3 cells in expression of the 170kD and 180kD forms of topoisomerase II.
    Woessner RD, Chung TD, Hofmann GA, Mattern MR, Mirabelli CK, Drake FH, Johnson RK.
    Cancer Res; 1990 May 15; 50(10):2901-8. PubMed ID: 2159365
    [Abstract] [Full Text] [Related]

  • 57. Decreased DNA topoisomerase II in daunorubicin-resistant Ehrlich ascites tumor cells.
    Friche E, Danks MK, Schmidt CA, Beck WT.
    Cancer Res; 1991 Aug 15; 51(16):4213-8. PubMed ID: 1678312
    [Abstract] [Full Text] [Related]

  • 58. Potentiation of topoisomerase inhibitor-induced DNA strand breakage and cytotoxicity by tumor necrosis factor: enhancement of topoisomerase activity as a mechanism of potentiation.
    Utsugi T, Mattern MR, Mirabelli CK, Hanna N.
    Cancer Res; 1990 May 01; 50(9):2636-40. PubMed ID: 2158396
    [Abstract] [Full Text] [Related]

  • 59. GTP induces knotting, catenation, and relaxation of DNA by stoichiometric amounts of DNA topoisomerase II from Bombyx mori and HeLa cells.
    Hirose S, Tabuchi H, Yoshinaga K.
    J Biol Chem; 1988 Mar 15; 263(8):3805-10. PubMed ID: 2831204
    [Abstract] [Full Text] [Related]

  • 60. Plant and Human MORC Proteins Have DNA-Modifying Activities Similar to Type II Topoisomerases, but Require One or More Additional Factors for Full Activity.
    Manohar M, Choi HW, Manosalva P, Austin CA, Peters JE, Klessig DF.
    Mol Plant Microbe Interact; 2017 Feb 15; 30(2):87-100. PubMed ID: 27992291
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.